JP2001269184A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001269184A5 JP2001269184A5 JP2000192401A JP2000192401A JP2001269184A5 JP 2001269184 A5 JP2001269184 A5 JP 2001269184A5 JP 2000192401 A JP2000192401 A JP 2000192401A JP 2000192401 A JP2000192401 A JP 2000192401A JP 2001269184 A5 JP2001269184 A5 JP 2001269184A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- protein
- salt
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 42
- 102000004169 proteins and genes Human genes 0.000 description 32
- 108090000623 proteins and genes Proteins 0.000 description 32
- 150000003839 salts Chemical class 0.000 description 26
- 102000000505 Ribonucleotide Reductases Human genes 0.000 description 17
- 108010041388 Ribonucleotide Reductases Proteins 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000192401A JP2001269184A (ja) | 1999-06-28 | 2000-06-27 | 新規タンパク質およびそのｄｎａ |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18113199 | 1999-06-28 | ||
| JP19239199 | 1999-07-06 | ||
| JP2000017770 | 2000-01-21 | ||
| JP11-192391 | 2000-01-21 | ||
| JP2000-17770 | 2000-01-21 | ||
| JP11-181131 | 2000-01-21 | ||
| JP2000192401A JP2001269184A (ja) | 1999-06-28 | 2000-06-27 | 新規タンパク質およびそのｄｎａ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001269184A JP2001269184A (ja) | 2001-10-02 |
| JP2001269184A5 true JP2001269184A5 (enExample) | 2007-09-06 |
Family
ID=27474982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000192401A Pending JP2001269184A (ja) | 1999-06-28 | 2000-06-27 | 新規タンパク質およびそのｄｎａ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001269184A (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08277300A (ja) * | 1995-02-07 | 1996-10-22 | Kyowa Hakko Kogyo Co Ltd | 抗リボヌクレオチドレダクターゼｒ２サブユニットモノクローナル抗体 |
| JPH1014582A (ja) * | 1996-07-08 | 1998-01-20 | Toagosei Co Ltd | リボヌクレオチドリダクターゼ |
| US6222029B1 (en) * | 1997-08-01 | 2001-04-24 | Genset | 5′ ESTs for secreted proteins expressed in brain |
| JP2003530815A (ja) * | 1998-09-17 | 2003-10-21 | インサイト・ファーマスーティカルズ・インコーポレイテッド | Ｒｎａ関連タンパク質 |
-
2000
- 2000-06-27 JP JP2000192401A patent/JP2001269184A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2102208A1 (en) | Binding domains in notch and delta proteins | |
| JP2004511201A5 (enExample) | ||
| JP2004534503A5 (enExample) | ||
| JP2002513556A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| CA2227516A1 (en) | Acylated oligopeptide derivatives having cell signal inhibiting activity | |
| ATE350049T1 (de) | Zusammensetzungen und verfahren zur behinderung der vervielfältigung von hiv-1 | |
| Rubin et al. | Backbone-cyclized peptides: a critical review | |
| JP2004531242A5 (enExample) | ||
| JPH08508884A (ja) | マクロファージ炎症蛋白変種 | |
| JPH02500517A (ja) | ペプチド化合物 | |
| JPH09289896A5 (enExample) | ||
| KR970701724A (ko) | 스타니어스 단백질인 스타니오칼신의 소체(Corpuscles of stannius protein, stanniocalcin) | |
| CA2413195A1 (en) | Ligand to gpr8 and dna thereof | |
| JP2001519823A (ja) | ウロキナーゼレセプターの抑制剤 | |
| CA2375605A1 (en) | Peptide leukotriene receptor | |
| JP2002345468A5 (enExample) | ||
| US5587457A (en) | Neutrophil stimulating peptides | |
| AU2957099A (en) | Novel physiologically active peptides and utilization thereof | |
| JP2001269184A5 (enExample) | ||
| JP2004513615A5 (enExample) | ||
| JP2008502323A5 (enExample) | ||
| JP3193085B2 (ja) | アンギオテンシン変換酵素阻害剤含有組成物の製造方法 | |
| Suzuki et al. | Localization of chemotactic activity and 64 kD protein phosphorylation for human polymorphonuclear leukocytes in N-terminus of the chemotactic protein LUCTIL-8 | |
| AU642487B2 (en) | Neutrophil stimulating peptides |